Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.

De Palo, G; Camerini, T; Marubini, E; Costa, A; Formelli, F; Del Vecchio, M; Mariani, L; Miceli, R; Mascotti, G; Magni, A; Campa, T; Di Mauro, M G; Attili, A; Maltoni, C; Del Turco, M R; Decensi, A; D'Aiuto, G; Veronesi, U

De Palo, G; Camerini, T; Marubini, E; Costa, A; Formelli, F; Del Vecchio, M; Mariani, L; Miceli, R; Mascotti, G; Magni, A; Campa, T; Di Mauro, M G; Attili, A; Maltoni, C; Del Turco, M R; Decensi, A; D'Aiuto, G; Veronesi, U.

Affiliation

De Palo G; Istituto Nazionale Tumori, University of Milan, Italy.

Tumori ; 83(6): 884-94, 1997.

Article in En | MEDLINE | ID: mdl-9526578

Subject(s)

Anticarcinogenic Agents/therapeutic use; Breast Neoplasms/prevention & control; Fenretinide/therapeutic use; Adult; Aged; Anticarcinogenic Agents/administration & dosage; Anticarcinogenic Agents/adverse effects; Breast Neoplasms/physiopathology; Drug Administration Schedule; Female; Fenretinide/administration & dosage; Fenretinide/adverse effects; Follow-Up Studies; Humans; Incidence; Middle Aged; Recurrence; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Anticarcinogenic Agents / Fenretinide Type of study: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Tumori Year: 1997 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links